Leading Analyst Recommendations: Upgrades and Downgrades Across Key Sectors
Money

Leading Analyst Recommendations: Upgrades and Downgrades Across Key Sectors

authorBy Scott Pape
DateJul 28, 2026
Read Time2 min
This article provides a consolidated overview of prominent analyst recommendations from Wall Street, detailing key upgrades, downgrades, and initial coverage reports that are influencing market movements. It serves as a crucial resource for investors seeking to understand shifts in expert opinions on various company stocks across different industries.

Unpacking Wall Street's Latest Insights: A Comprehensive View of Stock Recommendations

Significant Positive Revisions in Medical and Industrial Sectors

UBS has notably elevated its rating for Intuitive Surgical, shifting from 'Neutral' to 'Buy' and citing an undervaluation following a recent stock dip, coupled with expectations of dramatic acceleration in surgical automation. The firm also extended 'Buy' ratings to Stryker and Zimmer Biomet. Separately, Edwards Lifesciences received an upgrade to 'Buy' from UBS, fueled by its robust growth phase in TAVR adoption and a promising innovation pipeline. Bank of America upgraded Honeywell to 'Neutral' after stronger-than-expected Q2 results and an improved outlook. BNP Paribas turned positive on Nutrien, moving it to 'Outperform' based on optimistic fertilizer pricing. JPMorgan also upgraded International Paper to 'Overweight', anticipating significant pricing upside in the packaging sector.

Major Negative Revisions Impacting Tech, Consumer Goods, and Retail

TD Cowen has reduced its rating for Intuit to 'Hold' from 'Buy', citing a negative near-term catalyst path that could limit stock recovery. Jefferies downgraded Clorox to 'Hold', attributing the change to soft market trends and the appointment of a new CEO, which might lead to increased reinvestment and recalibrated expectations. UBS lowered Albertsons to 'Neutral' due to persistent consumer headwinds affecting demand in the grocery segment. Wells Fargo downgraded Levi Strauss to 'Equal Weight' following its recent stock rally, indicating a valuation concern. Additionally, TD Cowen moved RXO Inc. to 'Sell' from 'Hold', pointing to a tougher liability environment for large truckload brokers after recent court decisions.

New Analyst Coverage Introduced Across Diverse Industries

UBS initiated coverage for Becton Dickinson with a 'Buy' rating, highlighting its undervaluation and potential for growth as temporary headwinds dissipate. The firm also resumed coverage of DexCom with a 'Buy' rating, forecasting continued turnaround momentum and double-digit growth. Cooper Companies received a 'Neutral' rating from UBS, acknowledging a healthy eyecare sector but noting challenges in the refractive segment. Tandem Diabetes also saw coverage resumed by UBS with a 'Neutral' rating, with expectations of strong patient demand supporting market growth. Lastly, Stephens initiated coverage of H&R Block with an 'Equal Weight' rating, holding off on a 'Buy' despite easing fears due to uncertainties around its multiple recovery.

More Articles
Money
Liquidia Corporation: Significant Upside Predicted by Buckley Capital Advisors
Buckley Capital Advisors, in its Q2 2026 investor letter, highlighted Liquidia Corporation (NASDAQ:LQDA) as a key performer with over 50% potential upside. The firm anticipates a favorable ruling on Liquidia's Yutrepia product for PH-ILD, likely paving the way for a potential acquisition. Liquidia, a biopharmaceutical company focusing on cardiopulmonary diseases, has seen substantial share appreciation, driven by its promising therapeutic developments and strategic market position.
By Ramit SethiJul 28, 2026
Money
Boeing's Stellar Second Quarter: Exceeding Expectations and Boosting Cash Flow
Boeing announced its second-quarter earnings, surpassing revenue and cash flow projections, driven by increased jet deliveries. Despite a $280 million charge related to the new Air Force One program, the company achieved positive adjusted free cash flow, marking continued progress under CEO Kelly Ortberg's leadership. This performance indicates a robust recovery trajectory for the aerospace giant, with significant gains in commercial airplane revenue and promising developments in its defense sector.
By Natalie PaceJul 28, 2026
Money
T-Mobile US Faces Challenges from Emerging Network Competition
Carillon Tower Advisers' Q2 2026 investor letter reveals T-Mobile US (TMUS) underperformed due to concerns about a competitor's terrestrial mobile network development. Advances in low Earth orbit (LEO) satellite technology, combined with terrestrial solutions, could offer more affordable mobile connectivity. The investment firm, despite recognizing T-Mobile's potential, suggests that other AI stocks might present better upside with reduced risk. This highlights the evolving competitive landscape in the telecommunications sector, driven by technological innovations.
By Mr. Money MustacheJul 28, 2026
Money
Amkor Technology, Inc. Q2 2026 Earnings Insights
Amkor Technology reported robust Q2 2026 results with a 26% year-on-year revenue increase, driven by strong demand across computing and automotive sectors. The company is strategically migrating SiP production to Vietnam to enhance cost efficiency and expanding advanced packaging capabilities in Arizona. Despite some communication segment headwinds due to SiP transition and memory constraints, Amkor projects accelerated computing revenue in Q3, fueled by AI data center demand and new CPU programs.
By JL CollinsJul 28, 2026
Money
Apple Unveils New Device Leasing Program with Klarna Partnership
Apple has introduced a new device leasing initiative, "Apple Upgrade," in collaboration with payments provider Klarna. This program allows customers in the U.S. to lease iPhones, Macs, iPads, and Apple Watches through convenient monthly payment plans, replacing previous upgrade options and offering flexible terms.
By Dave RamseyJul 28, 2026